Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

- PMLiVE

NICE approves Vertex’s Casgevy one-time gene therapy for sickle cell disease

About 15,000 people in England are living with the inherited blood disorder

- PMLiVE

ICR researchers uncover new method for predicting bowel cancer risk in IBD patients

Approximately 500,000 people in the UK are affected by Crohn’s disease or ulcerative colitis

- PMLiVE

Keto, CAR-T and creativity: insights from ASH 2024

With a menu featuring everything from cutting-edge science to DEI and diet, ASH 2024 certainly offered congress attendees food for thought

- PMLiVE

See What’s Shaping Pharma Education in 2025: Join Our Free Webinar

From AI to VR, and everything in between—explore the cutting-edge tools revolutionizing medical training. Learn why these advancements are crucial for maintaining standards and excelling in the rapidly evolving landscape...

Impetus Digital

Optimizing Team Meetings in Remote Work – Building Company Culture Virtually

Rethink your approach to team meetings in a remote setting. Discover strategies for balancing synchronous and asynchronous communications to maximize decision-making and minimize meeting fatigue. Explore our tips for structuring...

Impetus Digital

- PMLiVE

UK access pathway launched to get new medicines to patients in ‘shortest time possible’

The ILAP offers drug developers a single platform to collaborate with the MHRA and HTA bodies

- PMLiVE

Sanofi’s Sarclisa combination approved by MHRA for newly diagnosed multiple myeloma

An estimated 5,900 new cases of the disease are diagnosed in the UK every year

- PMLiVE

Roche shares positive overall survival results for Itovebi in advanced breast cancer

Approximately 56,800 new cases of breast cancer are diagnosed in the UK every year

- PMLiVE

The AI tipping point in pharma marketing: balancing technology and trust

Taking a closer look at the opportunities and challenges AI offers pharma marketers

Biogen Idec building

Biogen’s higher dose spinal muscular atrophy regimen accepted for review by EMA/FDA

The neuromuscular disease affects approximately one in every 10,000 babies worldwide

- PMLiVE

Novo Nordisk’s Ozempic granted FDA approval in chronic kidney disease

The progressive condition affects approximately 40% of type 2 diabetes patients

Bayer symbol

Bayer UK launches digital educational hub to improve menopause support

An estimated 13 million women in the UK are currently perimenopausal or menopausal

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links